by Vora Corporate Finance | Jul 4, 2024 | Insights, Private Equity & IPO
Transaction: Quadria Capital, one of Asia’s largest healthcare-focused private equity firm invested INR 850 Crores in a series F funding round of NephroPlus, valuing the company at more than Rs. 2000 Crores. Through this transaction, Quadria acquires significant...
by Vora Corporate Finance | Jan 16, 2021 | Insights, Private Equity & IPO
Biocon Ltd., a bio-pharmaceutical company, announced that the Board of its subsidiary Biocon Biologics Ltd (Biocon Biologics) has approved a Rs.1,125 Crore (approx. USD 150 million) fund raise from Goldman Sachs. As per the proposed terms, Goldman Sachs will be issued...
by Karan Vora | Aug 29, 2020 | Debt Syndication, Financial Advisory, Insights, Private Equity & IPO
Economic Update: Monetary Policy committee of RBI met in 1st week of August and decided to keep the policy repo rate unchanged at 4% and continue with the accommodative stance of the monetary policy while ensuring that the inflation remains within target of 4% in...
by Karan Vora | Jan 11, 2020 | Insights
Indian Economic activity remained weak in the month of August as GDP slumped to 5.0 percent in Q1 2019-20. Monetary policy committee of RBI maintained the accommodative stance and slashed the repo rate by 35 basis points from 5.75% to 5.40% in July 2019. The rate was...
by Vora Corporate Finance | May 27, 2019 | Debt Syndication, Financial Advisory, Insights, Merger & Acquisitions, Private Equity & IPO
Summary This US based Healthcare IT firm was developing a Natural Language Processing platform with tie ups with Google and other leading players. It wanted to raise funds from US Private Equity Funds and needed a guidance for the negotiations. Vora Corporate Finance...
